Nusinersen in SMA 2 and 3: Risks vs benefits

Nusinersen in SMA 2 and 3: Risks vs benefits

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurology 2020-07, Vol.95 (4), p.151-152
1. Verfasser: Deymeer, Feza
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 152
container_issue 4
container_start_page 151
container_title Neurology
container_volume 95
creator Deymeer, Feza
description
doi_str_mv 10.1212/WNL.0000000000009919
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2424101988</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2424101988</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2783-512996abcddc3d6d2e9aadabadeeb9f744e22d943e870ba2c376fc4bf75c946f3</originalsourceid><addsrcrecordid>eNpdkE1LAzEQhoMoWKv_wEOOHtyaTNJN4q2IX1Ar-IHeQjaZpWu3u3Wza_Hfu7WC4lwG5n1mYB5CjjkbceBw9jKbjtifMoabHTLgY0iTVMDrLhkwBjoRWul9chDjG2N9qMyAnM66WFTYRKxoUdHHuwkF6qpAxTl9KOIi0o9IM6wwL9p4SPZyV0Y8-ulD8nx1-XRxk0zvr28vJtPEg9IiGXMwJnWZD8GLkAZA41xwmQuImcmVlAgQjBSoFcsceKHS3MssV2NvZJqLITnZ3l019XuHsbXLInosS1dh3UULEiRn3Gjdo3KL-qaOscHcrppi6ZpPy5ndyLG9HPtfzu_aui7b_vtF2a2xsXN0ZTv_xlPOZQIMGFOgWbIZCfEFPGBlaw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2424101988</pqid></control><display><type>article</type><title>Nusinersen in SMA 2 and 3: Risks vs benefits</title><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Deymeer, Feza</creator><creatorcontrib>Deymeer, Feza</creatorcontrib><identifier>ISSN: 0028-3878</identifier><identifier>EISSN: 1526-632X</identifier><identifier>DOI: 10.1212/WNL.0000000000009919</identifier><language>eng</language><publisher>American Academy of Neurology</publisher><ispartof>Neurology, 2020-07, Vol.95 (4), p.151-152</ispartof><rights>American Academy of Neurology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2783-512996abcddc3d6d2e9aadabadeeb9f744e22d943e870ba2c376fc4bf75c946f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Deymeer, Feza</creatorcontrib><title>Nusinersen in SMA 2 and 3: Risks vs benefits</title><title>Neurology</title><issn>0028-3878</issn><issn>1526-632X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpdkE1LAzEQhoMoWKv_wEOOHtyaTNJN4q2IX1Ar-IHeQjaZpWu3u3Wza_Hfu7WC4lwG5n1mYB5CjjkbceBw9jKbjtifMoabHTLgY0iTVMDrLhkwBjoRWul9chDjG2N9qMyAnM66WFTYRKxoUdHHuwkF6qpAxTl9KOIi0o9IM6wwL9p4SPZyV0Y8-ulD8nx1-XRxk0zvr28vJtPEg9IiGXMwJnWZD8GLkAZA41xwmQuImcmVlAgQjBSoFcsceKHS3MssV2NvZJqLITnZ3l019XuHsbXLInosS1dh3UULEiRn3Gjdo3KL-qaOscHcrppi6ZpPy5ndyLG9HPtfzu_aui7b_vtF2a2xsXN0ZTv_xlPOZQIMGFOgWbIZCfEFPGBlaw</recordid><startdate>20200728</startdate><enddate>20200728</enddate><creator>Deymeer, Feza</creator><general>American Academy of Neurology</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200728</creationdate><title>Nusinersen in SMA 2 and 3: Risks vs benefits</title><author>Deymeer, Feza</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2783-512996abcddc3d6d2e9aadabadeeb9f744e22d943e870ba2c376fc4bf75c946f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Deymeer, Feza</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Deymeer, Feza</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nusinersen in SMA 2 and 3: Risks vs benefits</atitle><jtitle>Neurology</jtitle><date>2020-07-28</date><risdate>2020</risdate><volume>95</volume><issue>4</issue><spage>151</spage><epage>152</epage><pages>151-152</pages><issn>0028-3878</issn><eissn>1526-632X</eissn><pub>American Academy of Neurology</pub><doi>10.1212/WNL.0000000000009919</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-3878
ispartof Neurology, 2020-07, Vol.95 (4), p.151-152
issn 0028-3878
1526-632X
language eng
recordid cdi_proquest_miscellaneous_2424101988
source Journals@Ovid Complete; Alma/SFX Local Collection
title Nusinersen in SMA 2 and 3: Risks vs benefits
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T02%3A47%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nusinersen%20in%20SMA%202%20and%203:%20Risks%20vs%20benefits&rft.jtitle=Neurology&rft.au=Deymeer,%20Feza&rft.date=2020-07-28&rft.volume=95&rft.issue=4&rft.spage=151&rft.epage=152&rft.pages=151-152&rft.issn=0028-3878&rft.eissn=1526-632X&rft_id=info:doi/10.1212/WNL.0000000000009919&rft_dat=%3Cproquest_cross%3E2424101988%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2424101988&rft_id=info:pmid/&rfr_iscdi=true